Here's the live share price of Vimta Labs along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Vimta Labs has gained 60.64% CAGR. Over the past year, the corresponding return has been 158.73%.
Vimta Labs’s current P/E of 51.96x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Best Pharmaceuticals and Healthcare Stocks Screener.
| Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) | 
|---|---|---|---|---|---|---|---|
| Vimta Labs | 6.51 | 0.12 | 3.19 | 40.64 | 158.31 | 49.85 | 60.64 | 
| Sun Pharma Advanced Research Company | 4.08 | 3.25 | -9.03 | -5.92 | -36.77 | -19.11 | -3.58 | 
| Suven Life Sciences | -3.78 | -7.47 | -29.75 | 56.48 | 52.62 | 46.67 | 31.27 | 
| Choksi Laboratories | -13.05 | -25.98 | -24.51 | 18.01 | 134.31 | 51.22 | 68.76 | 
| Vanta Bioscience | -12.77 | -6.03 | -23.44 | 9.78 | -55.21 | -33.60 | -31.93 | 
Over the last one year, Vimta Labs has gained 158.31% compared to peers like Sun Pharma Advanced Research Company (-36.77%), Suven Life Sciences (52.62%), Choksi Laboratories (134.31%). From a 5 year perspective, Vimta Labs has outperformed peers relative to Sun Pharma Advanced Research Company (-3.58%) and Suven Life Sciences (31.27%).
| Day | SMA | EMA | 
|---|---|---|
| 5 | 672.37 | 687.33 | 
| 10 | 681.5 | 687.7 | 
| 20 | 702.56 | 698.91 | 
| 50 | 726.61 | 695.99 | 
| 100 | 625.77 | 650.29 | 
| 200 | 555.84 | 573.42 | 
In the latest quarter, Vimta Labs saw a drop in promoter holding to 36.00%, while DII stake decreased to 0.87%, FII holding rose to 4.33%, and public shareholding moved up to 58.80% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
| Date Time | Announcement | 
|---|---|
| Oct 28, 2025, 11:38 PM IST | Vimta Labs Ltd. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | 
| Oct 28, 2025, 11:32 PM IST | Vimta Labs Ltd. - Board Meeting Intimation for Q2 FY2025-26- Financial Results - Board Meeting | 
| Oct 14, 2025, 7:01 PM IST | Vimta Labs Ltd. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | 
| Sep 26, 2025, 12:10 AM IST | Vimta Labs Ltd. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | 
| Sep 08, 2025, 11:44 PM IST | Vimta Labs Ltd. - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | 
Vimta Labs Ltd. is a Public Limited Listed company incorporated on 16/11/1990 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is L24110TG1990PLC011977 and registration number is 011977. Currently company belongs to the Industry of Medical Research Services. Company's Total Operating Revenue is Rs. 343.98 Cr. and Equity Capital is Rs. 4.45 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Vimta Labs is ₹715.90 as on Oct 30, 2025.
The Vimta Labs is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Vimta Labs is ₹3,188.68 Cr as on Oct 30, 2025.
Today’s highest and lowest price of Vimta Labs are ₹719.45 and ₹672.95.
The 52-week high/low is the highest and lowest price at which Vimta Labs stock has traded in the past 52-week or nearly a year. The 52-week high of Vimta Labs is ₹902.85 and 52-week low of Vimta Labs is ₹275.30 as on Oct 30, 2025.
The Vimta Labs has shown returns of 6.29% over the past day, 1.36% for the past month, 8.73% over 3 months, 158.73% over 1 year, 49.85% across 3 years, and 60.64% over 5 years.
P/E ratio of and PB ratio of Vimta Labs are 51.96 and 9.30 on Oct 30, 2025. While the company gives a dividend yield of 0.28 per annum.